Nothing Special   »   [go: up one dir, main page]

Witter et al., 1975 - Google Patents

Correlation between structure, behavioral activity and rate of biotransformation of some ACTH4-9 analogs.

Witter et al., 1975

View PDF
Document ID
14608281777165480998
Author
Witter A
Greven H
et al.
Publication year
Publication venue
Journal of Pharmacology and Experimental Therapeutics

External Links

Snippet

ABSTRACT WIrrER, ALBERT, HENK M. GREVEN AND DAVID DE\VIED Correlation between structure, behavioral activity and rate of biotransformation of some ACTH... 9 analogs. J. Pimarmacol. Exp. Timer. 193: 853-860, 1975. The effect of substitutions in …
Continue reading at citeseerx.ist.psu.edu (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68—Melanocyte-stimulating hormone [MSH]
    • C07K14/685—Melanocyte-stimulating hormone [MSH] alpha-Melanotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links

Similar Documents

Publication Publication Date Title
Witter et al. Correlation between structure, behavioral activity and rate of biotransformation of some ACTH4-9 analogs.
CA2367856C (en) Analogs of gastric inhibitory peptide and their use for treatment of diabetes
Wied et al. Release of ACTH by substances of central nervous system origin
JP3262329B2 (en) GLP-1 analog useful for the treatment of diabetes
MAEDA et al. Release of somatostatin and thyrotropin-releasing hormone from rat hypothalamic fragments in vitro
Steelman et al. The adipokinetic activities of the corticotrophins and melanocyte stimulating hormones
Gráf et al. Opioid agonist activity of β-lipotropin fragments: A possible biological source of morphine-like substances in the pituitary
PAPKOFF et al. Studies on the structure and function of interstitial cell-stimulating hormone
Maeda et al. Neurotensin release by rat hypothalamic fragments in vitro
US5217953A (en) Vasoactive intestinal peptide antagonist
Dockray et al. Vertebrate brain-gut peptides related to FMRFamide and Met-enkephalin Arg6Phe7
EP1363945B1 (en) Modified derivatives of cck-8
Abdel-Wahab et al. Insulin-releasing properties of the frog skin peptide pseudin-2 and its [Lys18]-substituted analogue
BADAMCHIAN et al. Complete amino acid sequence analysis of a peptide isolated from the thymus that enhances release of growth hormone and prolactin
Jean-Baptiste et al. In vitro cyclic AMP-mediated lipolytic activity of endorphins, enkephalins and naloxone
AU2002238701A1 (en) Modified derivatives of CCK-8
Ramachandran et al. Comparison of the steroidogenic and melanotropic activities of corticotropin, α-melanotropin and analogs with their lipolytic activities in rat and rabbit adipocytes
Hilsted Glycine-extended gastrin precursors
Weber et al. Specific binding and degradation of somatostatin by membrane vesicles from pig gut
Rosenthal et al. Structure-activity relationships of somatostatin analogs in the rabbit ileum and the rat colon
US4264492A (en) Enkephalin-like compounds in bovine adrenal medulla
Arakawa et al. Somatostatin-20: a novel NH2-terminally extended form of somatostatin isolated from porcine duodenum together with somatostatin-28 and somatostatin-25
Cheng et al. β-endorphin and its congeners in rat pituitary and thyroid: Effects of propylthiouracil and thyroid hormone administration
US20090281032A1 (en) Modified CCK peptides
AU669636B2 (en) Amylin antagonists and agonists